<DOC>
	<DOCNO>NCT00344695</DOCNO>
	<brief_summary>The purpose study 1 ) evaluate safety efficacy two dos bupropion SR ( 150mg/day 300mg/day ) compare placebo , aid smoking cessation adolescents 2 ) examine factor , medication adherence , nicotine dependence , motivation quit , affect treatment outcome .</brief_summary>
	<brief_title>Bupropion Treatment Youth Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>14 17 year age Smoked least 6 cigarette per day Exhaled CO great equal 10 ppm Made least two previous quit attempt Weighed least 90 pound Able read English least 6th grade level Motivated quit smoking evidence willingness commit study protocol requirement duration study provide active parental consent youth assent Current use tobacco product cigarettes , unless willing abstain product study duration Current use treatment smoke cessation History current diagnosis panic disorder , psychosis , bipolar disorder , eat disorder History abuse dependence alcohol recreational prescription drug three month precede study Current evidence clinical depression Attention Deficit/Hyperactivity Disorder Use psychoactive drug and/or type antidepressant four week treatment phase study Predisposition seizure tic disorder personal history seizure disorder , family history seizure disorder , treatment medication therapy increase risk seizure Significant history current clinical evidence cardiovascular disease ( Females ) Pregnancy ( urine pregnancy test ) , lactation , sexually active , unwillingness use medically acceptable form contraception duration study Only one member household allow participate study concurrently .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>